

HY-156671A · 1 mg
MedChemExpress · Cat: HY-156671A
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/rmc-4998-formic.html
Description
RMC-4998 formic is an orally active inhibitor targeting the active or GTP-bound state of the KRASG12C mutant. RMC-4998 formic can form a ternary complex with intracellular CYPA and the activated KRASG12C mutant, with an IC50 value of 28 nM. RMC-4998 formic can inhibit ERK signaling in KRASG12C mutant cancer cells and induce apoptosis. RMC-4998 formic can be used for non-small cell lung cancer NSCLC research.







